MX386696B - Proceso para producir analogos de anillo de arilomicina - Google Patents

Proceso para producir analogos de anillo de arilomicina

Info

Publication number
MX386696B
MX386696B MX2019011517A MX2019011517A MX386696B MX 386696 B MX386696 B MX 386696B MX 2019011517 A MX2019011517 A MX 2019011517A MX 2019011517 A MX2019011517 A MX 2019011517A MX 386696 B MX386696 B MX 386696B
Authority
MX
Mexico
Prior art keywords
sup
arilomycin
producing
ring analogues
ring
Prior art date
Application number
MX2019011517A
Other languages
English (en)
Other versions
MX2019011517A (es
Inventor
Allen Hong
Filip Petronijevic
Francis Gosselin
Haiyun Hou
Ngiap-Kie Lim
Nicholas Wong
Xin Linghu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2019011517A publication Critical patent/MX2019011517A/es
Publication of MX386696B publication Critical patent/MX386696B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Métodos para hacer un anillo de arilomicina de la fórmula t (ver fórmula) o sales o solvatos del mismo, en donde R, R1, R2, R3, R4, R5, R6, R7, R8, R9, R5, R10 y Pg1 son como se definen en la presente.
MX2019011517A 2017-03-27 2018-03-26 Proceso para producir analogos de anillo de arilomicina MX386696B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762477268P 2017-03-27 2017-03-27
PCT/US2018/024351 WO2018183198A1 (en) 2017-03-27 2018-03-26 Process for making arylomyin ring analogs

Publications (2)

Publication Number Publication Date
MX2019011517A MX2019011517A (es) 2019-11-18
MX386696B true MX386696B (es) 2025-03-19

Family

ID=61913697

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019011517A MX386696B (es) 2017-03-27 2018-03-26 Proceso para producir analogos de anillo de arilomicina

Country Status (14)

Country Link
US (2) US11192924B2 (es)
EP (1) EP3601240B1 (es)
JP (1) JP7041687B2 (es)
KR (1) KR102589474B1 (es)
CN (2) CN117777229A (es)
AU (2) AU2018243724B2 (es)
ES (1) ES2892173T3 (es)
HR (1) HRP20211495T1 (es)
IL (1) IL269532B (es)
MX (1) MX386696B (es)
PL (1) PL3601240T3 (es)
SG (1) SG11201908932SA (es)
SI (1) SI3601240T1 (es)
WO (1) WO2018183198A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180109858A (ko) 2015-11-20 2018-10-08 알큐엑스 파마슈티컬스, 인크. 마크로시클릭 광범위 항생제
UA126027C2 (uk) * 2017-02-15 2022-08-03 АрКьюЕкс ФАРМАСЬЮТІКЛС, ІНК. Макроциклічні антибіотики широкого спектра
IL288294B (en) * 2019-05-28 2022-09-01 Hoffmann La Roche A broad-spectrum macrocyclic antibiotic

Also Published As

Publication number Publication date
SI3601240T1 (sl) 2021-11-30
CA3057997A1 (en) 2018-10-04
CN110475766A (zh) 2019-11-19
PL3601240T3 (pl) 2021-12-20
EP3601240A1 (en) 2020-02-05
IL269532A (en) 2019-11-28
US11192924B2 (en) 2021-12-07
AU2022218486A1 (en) 2022-09-08
BR112019020112A2 (pt) 2020-05-05
WO2018183198A1 (en) 2018-10-04
JP2020512353A (ja) 2020-04-23
US20220056078A1 (en) 2022-02-24
IL269532B (en) 2021-12-01
AU2018243724A1 (en) 2019-10-03
US11702452B2 (en) 2023-07-18
CN110475766B (zh) 2023-12-29
KR20190133033A (ko) 2019-11-29
ES2892173T3 (es) 2022-02-02
KR102589474B1 (ko) 2023-10-16
AU2018243724B2 (en) 2022-07-28
AU2022218486B2 (en) 2023-09-28
JP7041687B2 (ja) 2022-03-24
CN117777229A (zh) 2024-03-29
SG11201908932SA (en) 2019-10-30
US20200255476A1 (en) 2020-08-13
MX2019011517A (es) 2019-11-18
EP3601240B1 (en) 2021-08-04
HRP20211495T1 (hr) 2021-12-24

Similar Documents

Publication Publication Date Title
AR132627A2 (es) Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos
MX394380B (es) Compuestos dinucleótidos cíclicos para eltratamiento de cáncer
EP4585268A3 (en) Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
MX2021011683A (es) Polimorfos de sepiapterina y sales de los mismos.
MX2021012973A (es) Sustituto de huevo y composiciones que comprenden el sustituto de huevo y metodos para producir el mismo.
MX393879B (es) Métodos de preparación de niraparib.
MX383935B (es) Amidas heterocíclicas como inhibidores de cinasa.
PH12020550703A1 (en) Sulfonamide compounds and use thereof
MX2018006288A (es) Inhibidores de acc tipo ester y usos de los mismos.
UY36175A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
CY1124450T1 (el) Νουκλεοτιδια βητα-νικοτινικου εστερα και διεργασιες για την παρασκευη αυτων
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
CO2017008600A2 (es) Análogos de desacetoxitubulisina h, composiciones y método de producción de los mismos
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
MX378847B (es) Nuevos derivados de gamma-amanitina
BR112019020338A8 (pt) Composição para produção de tagatose, e, método de produção de tagatose
CL2019001804A1 (es) Activador de nrf2.
UA117779C2 (uk) Піразини як модулятори gpr6
MY188420A (en) Crystalline forms of (s)-afoxolaner
CU24428B1 (es) Derivados de quinolizinona como inhibidores de pi3k
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
MX2020004093A (es) Puzolana de vidrio activada.
CO2020006542A2 (es) Profármacos de creatina, composiciones y métodos de uso de estos
CL2021000663A1 (es) Proceso para la producción de gas de síntesis.
CY1120812T1 (el) Υποκατεστημενα παραγωγα αζασπειρο(4.5)δεκανιου